| pubmed-article:11919663 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0009170 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0024400 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0058697 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0728938 | lld:lifeskim |
| pubmed-article:11919663 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:11919663 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11919663 | pubmed:dateCreated | 2002-3-28 | lld:pubmed |
| pubmed-article:11919663 | pubmed:abstractText | Dopamine D1 receptor partial agonists have been proposed as candidate medications for the treatment of cocaine dependence. However, there currently is scant information regarding how chronic exposure to D1 agonists may modify behavioral effects of cocaine and, especially, whether tolerance develops to their effects on cocaine self-administration. | lld:pubmed |
| pubmed-article:11919663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11919663 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11919663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11919663 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11919663 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11919663 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:11919663 | pubmed:author | pubmed-author:MutschlerNico... | lld:pubmed |
| pubmed-article:11919663 | pubmed:author | pubmed-author:BergmanJackJ | lld:pubmed |
| pubmed-article:11919663 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11919663 | pubmed:volume | 160 | lld:pubmed |
| pubmed-article:11919663 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11919663 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11919663 | pubmed:pagination | 362-70 | lld:pubmed |
| pubmed-article:11919663 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:meshHeading | pubmed-meshheading:11919663... | lld:pubmed |
| pubmed-article:11919663 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11919663 | pubmed:articleTitle | Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. | lld:pubmed |
| pubmed-article:11919663 | pubmed:affiliation | Harvard Medical School-McLean Hospital, Alcohol and Drug Abuse Research Center, 115 Mill Street, Belmont, MA 02478-9106, USA. | lld:pubmed |
| pubmed-article:11919663 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11919663 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11919663 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11919663 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11919663 | lld:pubmed |
